NCT01147237Unknown4 期
A Multi Center Registry to Evaluate Multiple Stenting Using by Everolimus-eluting Stents for Treatment of Long Coronary Artery Disease
Society for Advancement of Coronary Intervention Research33 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2010年2月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 发起方
- 入组人数
- 450
- 试验地点
- 33
- 主要终点
- Target lesion revascularization rate
研究概览
简要总结
The utilization of everolimus-eluting coronary stents in a coronary artery diseases is effective in reducing both repeat revascularization and major adverse cardiac events within two year follow-up. To evaluate the procedural, short and long term clinical outcomes of multiple everolimus-eluting coronary stent implantation in long (>30mm) coronary lesions.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age ≥20 years and are able to undergo CABG
- •Females who are not pregnant
- •Patients who present with angina symptoms or myocardial ischemia
- •Patients available for post-procedural observation and coronary angiography at 24 months
- •Patients who have signed patient informed consent
- •Lesion length is more than 30mm
- •De novo lesion or non-stented restenosed lesion
排除标准
- •Patients contraindicated for antiplatelet therapy or anticoagulant therapy
- •Patients with significant allergic reaction to contrast medium
- •Chronic total occlusion
- •Lesion with TIMI0
- •Patients with chronic renal failure (SCr>3.0mg/dl) -
结局指标
主要结局
Target lesion revascularization rate
时间窗: 1 year
次要结局
- Technical success(Initial)
- Angiographic restenosis(9 months)
- Target vessel revascularization(2 year)
- Target lesion revascularization(2 year)
- Incidences of acute, sub acute, and late stent thrombosis(2 year)
- Incidence of MACCE(2 year)
研究者
研究点 (33)
Loading locations...
相似试验
已完成
不适用
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm StudyAngioplastyChronic Coronary OcclusionStent ThrombosisVascular DiseaseCoronary Artery StenosisCoronary DiseaseCoronary RestenosisCoronary Artery DiseaseMyocardial IschemiaNCT01249027Abbott Medical Devices2,605
已完成
4 期
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)Coronary OcclusionThrombosis (Stent Thrombosis)Vascular DiseaseCoronary Artery StenosisCoronary DiseaseCoronary RestenosisCoronary Artery DiseaseMyocardial IschemiaNCT01178268Abbott Medical Devices546
已完成
4 期
Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES MellitusCoronary Artery DiseaseNCT00997763Seung-Jung Park300
已完成
不适用
Antiplatelet Therapy Following Stent ImplantationCoronary SyndromeAngina, UnstableAcute Myocardial InfarctionNCT02051361Elpen Pharmaceutical Co. Inc.900
已完成
不适用
MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR)de Novo or Restenosis LesionsNCT02828917Medinol Ltd.104